Anti-il-23p19 antibody formulations

PH12022550558B1Active Publication Date: 2026-08-05BOEHRINGER INGELHEIM INT GMBH

0 Cites 0 Cited by

Patent Information

Application Number: PH12022550558
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-03-08
Publication Date: 2026-08-05
Estimated Expiration: 2042-03-08

Application Information

Patent Timeline

08 Mar 2022

Application

PH12022550558

05 Aug 2026

Publication

PH12022550558B1

Inventors: GARIDEL, Patrick; SCHULTZ-FADEMRECHT, Torsten

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present disclosure inter alia provides a liquid pharmaceutical formulation comprising a) 150 mg / ml of an anti-IL-23p19 antibody, wherein the antibody comprises a light chain amino acid sequence according to SEQ ID NO: 1 and a heavy chain amino acid sequence according to SEQ ID NO: 2; b) a polyol; and c) a surfactant. The disclosed high concentration formulations are advantageously storage stable and suitable for subcutaneous administration.

Need to check novelty before this filing date? Find Prior Art